Infraredx Revenue and Competitors

Boston, MA USA

Location

$117.9M

Total Funding

Estimated Revenue & Valuation

  • Infraredx's estimated annual revenue is currently $25.6M per year.(i)
  • Infraredx received $20.0M in venture funding in November 2013.
  • Infraredx's estimated revenue per employee is $251,000
  • Infraredx's total funding is $117.9M.

Employee Data

  • Infraredx has 102 Employees.(i)
  • Infraredx grew their employee count by 4% last year.

Infraredx's People

NameTitleEmail/Phone
1
VP Human ResourcesReveal Email/Phone
2
SVP, Clinical, Regulatory & ResearchReveal Email/Phone
3
Director Biomedical ResearchReveal Email/Phone
4
Director ReimbursementReveal Email/Phone
5
Director Global Clinical TrainingReveal Email/Phone
6
Director Sales & MarketingReveal Email/Phone
7
Director Clinical Research and RegulatoryReveal Email/Phone
8
Director AccountingReveal Email/Phone
9
Director QualityReveal Email/Phone
10
Director Hardware EngineeringReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.8M393%N/AN/A
#2
$8.5M343%N/AN/A
#3
$3M12-29%N/AN/A
#4
$5630M7477-11%$450MN/A
#5
$4.5M186%N/AN/A
#6
$7.2M5727%$29.6MN/A
#7
$14.3M57-12%N/AN/A
#8
$2.3M186%$44MN/A
#9
$40.7M162-1%N/AN/A
#10
$45.7M182-5%N/AN/A
Add Company

What Is Infraredx?

There are still broad swaths of uncharted territories concerning the role lipid core plaques play in heart disease. Now, you can achieve unparalleled insights with the Infraredx Dualpro IVUS+NIRS catheter and its accompanying Makoto Intravascular Imaging System, the only FDA-cleared dual-modality catheter and imaging system indicated for the detection of lipid core plaque (LCP). Anything else, and you are leaving valuable data on the table. For more information about the Makoto Imaging System or Dualpro IVUS+NIRS Catheter visit www.infraredx.com. Infraredx is an intravascular imaging company committed to advancing the diagnosis and management of coronary artery disease globally. Harnessing 30 years of research into the association between heart attacks and lipid-core plaques, Infraredx has been committed to the design, manufacture, and distribution of technologies that address the needs of practitioners and improve outcomes in the treatment of patients with coronary artery disease. With ongoing investment in several landmark global clinical trials, Infraredx's mission, to enable cardiologists to predict heart attacks and prevent them, continues.

keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

$117.9M

Total Funding

102

Number of Employees

$25.6M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Infraredx News

2022-04-20 - Intracardiac Echocardiography Market Outlook 2022-2030 ...

Intracardiac Echocardiography Market Outlook 2022-2030| Key Players – Infraredx, Inc, Boston Scientific Corporation, Abbott. The latest market research report...

2022-04-20 - Intravascular Ultrasound Market Size, Outlook And Forecast ...

Boston Scientific, InfraReDx, Draegerwerk, Smiths Medical, Philips Respironics, Avinger, Terumo, Medtronic, GE Healthcare, Siemens Healthcare, Volcano,...

2022-04-19 - Global Intravascular Ultrasound (IVUS) Devices Market 2022 ...

... 2022-2028 (Impact of Covid-19) | Koninklijke Philips N.V., Cytiva (GE Healthcare), Siemens AG, Boston Scientific Corporation, Infraredx.

2013-08-22 - Infraredx Receives $25M Equity Investment from Nipro

Infraredx, Inc., a Burlington, Mass.-based medical device company committed to advancing the diagnosis and management of coronary artery disease, received a $25m equity investment from Nipro Corporation. In conjunction with the investment, a member of Nipro’s management team will join Infraredx ...

2011-12-05 - InfraReDx Receives $10M Loan from GE Capital, Healthcare Financial Services

InfraReDx, Inc., a Burlington, MA-based medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, has received a $10m senior secured multi-draw term loan from GE Capital, Healthcare Financial Services. InfraReDx intends to use the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.5M1022%N/A
#2
$32.9M1023%N/A
#3
N/A10421%N/A
#4
$33.6M1046%N/A
#5
$7.5M1056%N/A

Infraredx Funding

DateAmountRoundLead InvestorsReference
2011-06-29$24.1MUndisclosedArticle
2011-12-06$10.0MUndisclosedGE Capital Healthcare FinanciaArticle
2013-08-22$25.0MUndisclosedNipro CorporationArticle
2013-11-06$20.0MUndisclosedGE Capital, Healthcare FinanciaArticle